RXi Pharmaceuticals enters into exclusive option agreement to acquire Mirimmune Inc
Thursday, October 13, 2016
RXi Pharmaceuticals enters into exclusive option agreement to acquire Mirimmune Inc. RXi Pharmaceuticals Corp - can exercise option to acquire Mirimmune on terms set forth in option agreement at any time prior to April 5, 2017.
RXi Pharmaceuticals Corp - deal for number of shares equal to 19.99% of then outstanding shares of common stock of RXi.
RXi Pharmaceuticals Corp - entered into an option agreement to acquire all outstanding capital stock of Mirimmune Inc. RXi Pharmaceuticals Corp - deal also provides for additional potential consideration contingent on Mirimmune reaching certain milestones.
Source : reuters.com
